{"database": "lobbying", "table": "lobbying_activities", "rows": [[3006815, "9a6045ac-fac7-4d81-99aa-70b25598f8f6", "Q2", "RICCHETTI INCORPORATED", 62778, "NEUROCRINE BIOSCIENCES, INC.", 2023, "second_quarter", "PHA", "Issues related to pharmaceutical industry, generally", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2023-07-17T11:52:06-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3006815"], "units": {}, "query_ms": 0.3736440557986498, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}